HAIYING ZHANG: Open Payments
NPI 1205609237 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,470 in 71 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $872 · 2025 $1,470
Food & beverage: $1,470
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $233 |
| ABBVIE INC. | 15 | $217 |
| AstraZeneca Pharmaceuticals LP | 11 | $213 |
| PFIZER INC. | 9 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $160 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Lilly USA, LLC | 3 | $46 |
| Exact Sciences Corporation | 2 | $33 |
| Ardelyx, Inc. | 1 | $32 |
Products named: NURTEC ODT, Ozempic, Kerendia, VRAYLAR, TRELEGY ELLIPTA, BREZTRI, AIRSUPRA, GARDASIL 9.
Industry payments across AZ — which companies pay providers there.
